15.12USD-0.23%Mkt Cap: 204.12M USDP/E: —Last update: 2026-06-01
Immunic, Inc., a biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany. Its lead development …
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap204.12M USD
Enterprise Value17.30M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-97.17M USD
Revenue/Share—
Last Price15.12 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees92
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS4525EP1011
Valuation
P/E (Trailing)—
P/E (Forward)-4.22
PEG—
EV/EBITDA-0.16
EV/Revenue—
P/S—
P/B-27.00
EPS (TTM)-4.77
EPS (Forward)-3.55
52W Range
5.06094% of range15.77
52W High15.77 USD
52W Low5.060 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE1456.20%
ROA-404.01%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-85.81M USD
CapEx (TTM)161.00K USD
FCF Margin—
FCF Yield-21.33%
Net Debt-186.48M USD
Net Debt/EBITDA1.70
Balance Sheet
Debt/Equity-0.09
Current Ratio4.92
Quick Ratio4.87
Book Value/Sh-0.5540 USD
Cash/Share13.70 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateApr 15, 2019
Splits
Last Split1:10
Split DateApr 27, 2026
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)44.67 USD
Target Range19.00 USD – 85.00 USD
# Analysts9
Ownership
Shares Out.13.62M
Float10.49M
Insiders0.97%
Institutions44.49%
Short Interest
Short Ratio4.5d
Short % Float11.61%
Short % Out.11.50%
Shares Short1.57M
Short (prev mo.)832.77K
Technical
SMA 5011.41 (+32.6%)
SMA 2008.859 (+70.7%)
Beta—
S&P 52W Chg27.94%
Avg Vol (30d)301.76K
Avg Vol (10d)244.94K
Technical Indicators
RSI (14)71.5
MACD0.9251
MACD Signal0.5755
MACD Hist.+0.3497
BB Upper15.04 USD
BB Middle12.26 USD
BB Lower9.475 USD
BB Width45.39%
ATR (14)1.186 USD
Vol Ratio (20d)1.14x